Systematic review of the impact of N-acetylcysteine on contrast nephropathy
Top Cited Papers
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 65 (4) , 1366-1374
- https://doi.org/10.1111/j.1523-1755.2004.00516.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nephrotoxic Effects in High-Risk Patients Undergoing AngiographyNew England Journal of Medicine, 2003
- Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and InterventionJAMA, 2003
- A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiographyKidney International, 2002
- Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathyCatheterization and Cardiovascular Interventions, 2002
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- Contrast NephropathyJournal of the American Society of Nephrology, 2000
- Acute Renal Failure After Coronary InterventionThe American Journal of Medicine, 1997
- Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.Radiology, 1993
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981
- Renal failure after major angiographyThe American Journal of Medicine, 1980